Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

TECH – Bio-Techne Corporation

Bio-Techne Corp
TECH
$54.89
Name : Bio-Techne Corp
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $8,604,941,312.00
EPSttm : 0.83
finviz dynamic chart for TECH
Bio-Techne Corp
$54.89
0.29%
$0.16

Float Short %

4.21

Margin Of Safety %

39

Put/Call OI Ratio

0.51

EPS Next Q Diff

-0.12

EPS Last/This Y

0.14

EPS This/Next Y

0.15

Price

54.89

Target Price

66.71

Analyst Recom

1.67

Performance Q

10.6

Relative Volume

0.75

Beta

1.39

Ticker: TECH




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04TECH53.140.281.004982
2025-07-07TECH51.540.281.504984
2025-07-08TECH52.680.280.174996
2025-07-09TECH52.60.283.805025
2025-07-10TECH54.380.290.065056
2025-07-11TECH54.260.280.075168
2025-07-14TECH52.620.281.845199
2025-07-15TECH51.420.310.225308
2025-07-16TECH51.790.330.025595
2025-07-17TECH53.310.330.295638
2025-07-18TECH52.140.3310.095656
2025-07-21TECH50.260.401.463614
2025-07-22TECH53.130.410.033705
2025-07-23TECH55.30.380.413915
2025-07-24TECH58.470.430.798647
2025-07-25TECH58.780.530.769640
2025-07-28TECH58.590.532.289648
2025-07-29TECH57.870.540.779635
2025-07-30TECH57.740.541.759643
2025-07-31TECH54.720.530.519626
2025-08-01TECH54.90.510.1311214
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04TECH53.142.5183.21.91
2025-07-07TECH51.532.5173.01.91
2025-07-08TECH52.682.5191.11.91
2025-07-09TECH52.592.5182.81.91
2025-07-10TECH54.412.5195.31.91
2025-07-11TECH54.142.5193.51.91
2025-07-14TECH52.622.5173.81.91
2025-07-15TECH51.422.5175.61.91
2025-07-16TECH51.782.5185.81.91
2025-07-17TECH53.292.5193.31.91
2025-07-18TECH52.022.5175.21.91
2025-07-21TECH50.262.5171.81.91
2025-07-22TECH53.112.5202.81.91
2025-07-23TECH55.312.5197.61.91
2025-07-24TECH58.472.0203.11.91
2025-07-25TECH58.782.0185.31.91
2025-07-28TECH58.702.0182.91.91
2025-07-29TECH57.872.0179.41.91
2025-07-30TECH57.712.0182.61.91
2025-07-31TECH54.732.0165.61.91
2025-08-01TECH54.892.0184.51.91
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04TECH-0.923.943.96
2025-07-07TECH-0.923.943.96
2025-07-08TECH-0.923.943.96
2025-07-09TECH-0.923.943.96
2025-07-10TECH-0.923.943.96
2025-07-11TECH-0.923.944.07
2025-07-14TECH-0.924.424.07
2025-07-15TECH-0.924.424.07
2025-07-16TECH-0.924.424.07
2025-07-17TECH-0.924.424.07
2025-07-18TECH-0.924.424.07
2025-07-21TECH-0.924.574.07
2025-07-22TECH-0.924.574.07
2025-07-23TECH-0.924.574.07
2025-07-24TECH-0.924.574.07
2025-07-25TECH-0.924.574.21
2025-07-28TECH-0.922.574.21
2025-07-29TECH-0.922.574.21
2025-07-30TECH-0.182.574.21
2025-07-31TECH-0.182.574.21
2025-08-01TECH-0.182.574.21
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.56

Avg. EPS Est. Current Quarter

0.5

Avg. EPS Est. Next Quarter

0.44

Insider Transactions

-0.18

Institutional Transactions

2.57

Beta

1.39

Average Sales Estimate Current Quarter

315

Average Sales Estimate Next Quarter

298

Fair Value

76.07

Quality Score

88

Growth Score

80

Sentiment Score

38

Actual DrawDown %

59.6

Max Drawdown 5-Year %

-64.8

Target Price

66.71

P/E

66.91

Forward P/E

26.79

PEG

6.79

P/S

7.12

P/B

4.26

P/Free Cash Flow

38.98

EPS

0.82

Average EPS Est. Cur. Y​

1.91

EPS Next Y. (Est.)

2.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

10.89

Relative Volume

0.75

Return on Equity vs Sector %

-17.2

Return on Equity vs Industry %

1.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

184.5
Bio-Techne Corp
Sector: Healthcare
Industry: Biotechnology
Employees: 3100
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. The company has strategic partnership with ALZpath, Inc. to accelerate breakthroughs in neurodegenerative disease research and treatment, including Alzheimer's disease. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was incorporated in 1976 and is headquartered in Minneapolis, Minnesota.
stock quote shares TECH – Bio-Techne Corporation Stock Price stock today
news today TECH – Bio-Techne Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch TECH – Bio-Techne Corporation yahoo finance google finance
stock history TECH – Bio-Techne Corporation invest stock market
stock prices TECH premarket after hours
ticker TECH fair value insiders trading